Novocure announced that it has elected Martin J. Madden to its Board of Directors in the meeting of shareholders.
Mr. Madden recently retired after a 30-year career in medical device innovation at Johnson & Johnson. Mr. Madden is also a member of the Board of Directors for Microbot Medical Inc. He most recently served as VP, Research and Development DePuy-Synthes and VP Medical Device R&D Transformation. Earlier in his career, Mr. Madden was a medical device engineer and innovator, and a leader of cross-functional teams charged with incubating, developing, and launching new products. Mr. Madden holds an MBA from Columbia University, a Master’s degree in Mechanical Engineering from Carnegie-Mellon University and a Bachelor’s degree in Mechanical Engineering from the University of Dayton.
Novocure’s Executive Chairman, Bill Doyle said that they are extremely pleased to welcome Martin to their board. Martin’s extensive experience as a leader of medical device development and commercialization will be invaluable as they continue to execute their mission to bring a profoundly different cancer treatment to patients.